Displaying 3861 - 3880 of 4805
Equitable Resources, Inc., Dominion Resources, Inc., Consolidated Natural Gas Company, and The Peoples Natural Gas Company
The Commission charged that Schering-Plough’s proposed $14.4 billion acquisition of Organon Biosciences N.V. threatened to substantially reduce competition in the U.S. market for three popular vaccines used to treat poultry, a staple in American food markets. The November 2007 order settling the charges required the sale of assets required to develop, manufacture, and market these vaccines to Wyeth. In addition, Schering-Plough was required to sign a supply and transition services agreement with Wyeth, under which Schering will provide the vaccines for a period of two years, allowing time for the necessary FDA approvals.
0802006 Informal Interpretation
FTC Submits Testimony to Alaska House of Representatives Regarding Bill That Would Amend States Certificate of Need Laws
FTC Staff Submits Comments on Establishing Collective Bargaining for Independent Home Care Providers in Ohio
FTC Staff Issues Advisory Opinion to Kaiser Foundation Health Plan, Inc., Concerning Non-Profit Institutions Act
FTC Sues Cephalon, Inc. for Unlawfully Blocking Sale of Lower-Cost Generic Versions of Branded Drug Until 2012
Unilateral Effects Analysis and Litigation Workshop
FTC Staff Extends Comment Period for Proposed Online Behavioral Advertising Principles; Commission Approves Final Consent Orders in Matters of Milliman, Inc. and Ingenix, Inc.
FTC To Host Public Workshop on Unilateral Effects Analysis and Litigation
Charting the Future Course of International Technical Assistance
FTC Releases Agenda for Public Workshop on Unilateral Effects Analysis and Litigation
FTC Dismisses Administrative Complaint Challenging Acquisition of The Peoples Natural Gas Company from Dominion Resources, Inc.
Equitable Resources, Inc., Dominion Resources, Inc., Consolidated Natural Gas Company, and The Peoples Natural Gas Company, In the Matter of
Commission Staff Files Comments with Puerto Ricos Treasury and Financial Affairs Commission on Health Care Collective Bargaining Bill
Schering-Plough Corporation, In the Matter of
The Commission charged that Schering-Plough’s proposed $14.4 billion acquisition of Organon Biosciences N.V. threatened to substantially reduce competition in the U.S. market for three popular vaccines used to treat poultry, a staple in American food markets. The November 2007 order settling the charges required the sale of assets required to develop, manufacture, and market these vaccines to Wyeth. In addition, Schering-Plough was required to sign a supply and transition services agreement with Wyeth, under which Schering will provide the vaccines for a period of two years, allowing time for the necessary FDA approvals.
Great Atlantic & Pacific Tea Company, The, Inc., and Pathmark Stores, Inc., In the Matter of
The Commission intervened in the proposed $1.3 billion acquisition of Pathmark Stores by Great Atlantic & Pacific Tea (A&P), alleging the transaction would have reduced competition among grocery stores in the highly concentrated markets of Staten Island and Shirley, Long Island, New York. A&P operates stores under the A&P, A&P Super Foodmart, Food Basics, Food Emporium, Super Fresh, and Waldbaum’s banners. The Commission’s consent order required A&P to divest five supermarkets in Staten Island, and one supermarket in Shirley.
Commission Announces Issuance of Information Requests to Generic and Authorized Generic Drug Companies; FTC Approves Proposed Divestiture in Matter of SCI and Alderwoods Group; Commission Approves Proposed Divestiture in Matter of Kyphon, Inc.
Displaying 3861 - 3880 of 4805